Abstract: Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).
Type:
Application
Filed:
September 27, 2019
Publication date:
February 6, 2020
Applicant:
SYMBIOMIX THERAPEUTICS, LLC
Inventors:
Helen S. PENTIKIS, David PALLING, Carol J. BRAUN
Abstract: Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).
Type:
Application
Filed:
September 27, 2019
Publication date:
January 23, 2020
Applicant:
SYMBIOMIX THERAPEUTICS, LLC
Inventors:
Helen S. PENTIKIS, David PALLING, Carol J. BRAUN
Abstract: Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).
Type:
Application
Filed:
May 3, 2019
Publication date:
August 22, 2019
Applicant:
SYMBIOMIX THERAPEUTICS, LLC
Inventors:
Helen S. PENTIKIS, David PALLING, Carol J. BRAUN
Abstract: Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).
Type:
Grant
Filed:
September 4, 2015
Date of Patent:
July 2, 2019
Assignee:
Symbiomix Therapeutics, LLC
Inventors:
Helen S. Pentikis, David Palling, Carol J. Braun
Abstract: Embodiments described herein are directed to novel soft gelatin capsule formulations for intravaginal administration comprising secnidazole compounds and methods and uses of these pharmaceutical compositions in the treatment of bacterial vaginosis.
Type:
Application
Filed:
June 21, 2018
Publication date:
January 10, 2019
Applicant:
SYMBIOMIX THERAPEUTICS, LLC
Inventors:
ROBERT JACKS, LINUS FONKWE, IRENA MCGUFFY
Abstract: Method of treating bacterial vaginosis in a subject in need thereof involving administering to the subject a therapeutically effective amount of secnidazole in a microgranule formulation, wherein the microgranule formulation comprises a plurality of microgranules having a volume-weighted particle size distribution within a microgranule population, wherein the volume-weighted particle size distribution as measured from a representative sample of the microgranule population comprises (a) 10% of the microgranule population having a volume-weighted particle size about no less than 470 micrometers; (b) 50% of the microgranule population having a volume-weighted particle size between about no less than 640 micrometers and about no more than 810 micrometers; (c) 90% of the microgranule population having a volume-weighted particle size about no more than 1170 micrometers; or (d) a combination thereof, which can include some or all of (a) through (c) above.
Type:
Application
Filed:
July 30, 2018
Publication date:
November 22, 2018
Applicant:
SYMBIOMIX THERAPEUTICS, LLC
Inventors:
Helen S. PENTIKIS, David PALLING, Carol J. BRAUN, Richard HOLL
Abstract: Embodiments described herein are directed to novel pharmaceutical compositions comprising a plurality of microgranules comprising nitroimidazole compounds, and uses of these pharmaceutical compositions in the treatment of bacterial vaginosis.
Type:
Application
Filed:
June 1, 2016
Publication date:
December 1, 2016
Applicant:
SYMBIOMIX THERAPEUTICS, LLC
Inventors:
David PALLING, Ronald S. VLADYKA, Joseph AMPREY